$SNSS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Viracta Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Viracta Therapeutics, Inc.. Get notifications about new insider transactions in Viracta Therapeutics, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 13 2021 | SNSS | Viracta Therapeuti ... | Rojkjaer Lisa | Chief Medical Offic ... | Option Exercise | M | 3.58 | 2,061 | 7,378 | 30,956 | |
May 13 2021 | SNSS | Viracta Therapeuti ... | Rojkjaer Lisa | Chief Medical Offic ... | Option Exercise | M | 1.26 | 32,689 | 41,188 | 98,069 | |
May 13 2021 | SNSS | Viracta Therapeuti ... | Rojkjaer Lisa | Chief Medical Offic ... | Buy | M | 3.58 | 2,061 | 7,378 | 34,750 | 32.7 K to 34.8 K (+6.30 %) |
May 13 2021 | SNSS | Viracta Therapeuti ... | Rojkjaer Lisa | Chief Medical Offic ... | Buy | M | 1.26 | 32,689 | 41,188 | 32,689 | 0 to 32.7 K |
Mar 30 2021 | SNSS | Viracta Therapeuti ... | Rojkjaer Lisa | Chief Medical Offic ... | Option Exercise | A | 8.74 | 126,890 | 1,109,019 | 126,890 | |
Mar 30 2021 | SNSS | Viracta Therapeuti ... | ONETTO NICOLE | Director | Option Exercise | A | 8.74 | 80,000 | 699,200 | 80,000 | |
Mar 30 2021 | SNSS | Viracta Therapeuti ... | Huang Michael | Director | Option Exercise | A | 8.74 | 80,000 | 699,200 | 80,000 | |
Mar 30 2021 | SNSS | Viracta Therapeuti ... | Simon Barry J. | Director | Option Exercise | A | 8.74 | 80,000 | 699,200 | 80,000 | |
Mar 30 2021 | SNSS | Viracta Therapeuti ... | Roshwalb Gur | Director | Option Exercise | A | 8.74 | 80,000 | 699,200 | 80,000 | |
Mar 30 2021 | SNSS | Viracta Therapeuti ... | DARCY THOMAS E | Director | Option Exercise | A | 8.74 | 80,000 | 699,200 | 80,000 | |
Mar 30 2021 | SNSS | Viracta Therapeuti ... | Murphy Samuel Lafayette | Director | Option Exercise | A | 8.74 | 80,000 | 699,200 | 80,000 | |
Mar 30 2021 | SNSS | Viracta Therapeuti ... | Pomerantz Roger | Director | Option Exercise | A | 8.74 | 135,000 | 1,179,900 | 135,000 | |
Mar 30 2021 | SNSS | Viracta Therapeuti ... | Rubino Stephen | Director | Option Exercise | A | 8.74 | 80,000 | 699,200 | 80,000 | |
Mar 30 2021 | SNSS | Viracta Therapeuti ... | ROYSTON IVOR | CEO & President | Option Exercise | A | 8.74 | 441,993 | 3,863,019 | 441,993 | |
Mar 30 2021 | SNSS | Viracta Therapeuti ... | Chevallard Daniel R. | CFO and COO | Option Exercise | A | 8.74 | 78,912 | 689,691 | 78,912 | |
Jul 01 2020 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | See Remarks | Option Exercise | A | 0.26 | 60,000 | 15,804 | 60,000 | |
Jul 01 2020 | SNSS | SUNESIS PHARMACEUT ... | Pearce Homer L | Director | Option Exercise | A | 0.26 | 60,000 | 15,804 | 60,000 | |
Jul 01 2020 | SNSS | SUNESIS PHARMACEUT ... | ONETTO NICOLE | Director | Option Exercise | A | 0.26 | 45,000 | 11,853 | 45,000 | |
Jul 01 2020 | SNSS | SUNESIS PHARMACEUT ... | Wolff Henry Ward | Director | Option Exercise | A | 0.26 | 60,000 | 15,804 | 60,000 | |
Jul 01 2020 | SNSS | SUNESIS PHARMACEUT ... | YOUNG JAMES W | Director | Option Exercise | A | 0.26 | 60,000 | 15,804 | 60,000 | |
Jul 01 2020 | SNSS | SUNESIS PHARMACEUT ... | Carchedi Steve | Director | Option Exercise | A | 0.26 | 60,000 | 15,804 | 60,000 | |
Jul 01 2020 | SNSS | SUNESIS PHARMACEUT ... | Ketchum Steven B | Director | Option Exercise | A | 0.26 | 60,000 | 15,804 | 60,000 | |
Jul 01 2020 | SNSS | SUNESIS PHARMACEUT ... | STUMP DAVID C | Director | Option Exercise | A | 0.26 | 60,000 | 15,804 | 60,000 | |
Jun 05 2020 | SNSS | SUNESIS PHARMACEUT ... | Gullotta Tina | VP, Finance | Option Exercise | A | 0.39 | 70,000 | 27,300 | 70,000 | |
Jun 05 2020 | SNSS | SUNESIS PHARMACEUT ... | Gullotta Tina | VP, Finance | Buy | P | 0.33 | 6,000 | 1,989 | 20,500 | 14.5 K to 20.5 K (+41.38 %) |
Apr 02 2020 | SNSS | SUNESIS PHARMACEUT ... | Quinn William P. | See Remarks | Option Exercise | A | 0.41 | 360,000 | 149,364 | 360,000 | |
Apr 02 2020 | SNSS | SUNESIS PHARMACEUT ... | Quinn William P. | See Remarks | Buy | P | 0.37 | 6,000 | 2,193 | 127,697 | 121.7 K to 127.7 K (+4.93 %) |
Apr 02 2020 | SNSS | SUNESIS PHARMACEUT ... | Quinn William P. | See Remarks | Buy | P | 0.65 | 6,000 | 3,877 | 121,697 | 115.7 K to 121.7 K (+5.19 %) |
Apr 02 2020 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Interim CEO | Option Exercise | A | 0.41 | 480,000 | 199,152 | 480,000 | |
Apr 02 2020 | SNSS | SUNESIS PHARMACEUT ... | Fox Judith A. | See Remarks | Option Exercise | A | 0.41 | 457,500 | 189,817 | 457,500 | |
Oct 01 2019 | SNSS | SUNESIS PHARMACEUT ... | ONETTO NICOLE | Director | Option Exercise | A | 0.72 | 90,000 | 64,791 | 90,000 | |
Aug 12 2019 | SNSS | SUNESIS PHARMACEUT ... | Fox Judith A. | See Remarks | Option Exercise | A | 0.86 | 15,000 | 12,900 | 15,000 | |
Jul 15 2019 | SNSS | SUNESIS PHARMACEUT ... | Aisling Capital IV, LP | 10% Owner | Buy | P | 0.60 | 2,500,000 | 1,500,000 | 10,100,000 | 7.6 M to 10.1 M (+32.89 %) |
Jul 02 2019 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Interim CEO | Option Exercise | A | 0.73 | 480,000 | 348,864 | 480,000 | |
Jul 02 2019 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Interim CEO | Option Exercise | A | 0.73 | 60,000 | 43,608 | 60,000 | |
Jul 02 2019 | SNSS | SUNESIS PHARMACEUT ... | YOUNG JAMES W | Director | Option Exercise | A | 0.73 | 60,000 | 43,608 | 60,000 | |
Jul 02 2019 | SNSS | SUNESIS PHARMACEUT ... | Carchedi Steve | Director | Option Exercise | A | 0.73 | 60,000 | 43,608 | 60,000 | |
Jul 02 2019 | SNSS | SUNESIS PHARMACEUT ... | Ketchum Steven B | Director | Option Exercise | A | 0.73 | 60,000 | 43,608 | 60,000 | |
Jul 02 2019 | SNSS | SUNESIS PHARMACEUT ... | STUMP DAVID C | Director | Option Exercise | A | 0.73 | 60,000 | 43,608 | 60,000 | |
Jul 02 2019 | SNSS | SUNESIS PHARMACEUT ... | Wolff Henry Ward | Director | Option Exercise | A | 0.73 | 60,000 | 43,608 | 60,000 | |
Apr 01 2019 | SNSS | SUNESIS PHARMACEUT ... | Quinn William P. | See Remarks | Option Exercise | A | 1.22 | 75,000 | 91,125 | 75,000 | |
Mar 04 2019 | SNSS | SUNESIS PHARMACEUT ... | Quinn William P. | See Remarks | Grant | A | 0.00 | 63,697 | 0 | 115,697 | 52 K to 115.7 K (+122.49 %) |
Jan 03 2019 | SNSS | SUNESIS PHARMACEUT ... | Quinn William P. | CFO,Sr.V.P. Finance ... | Option Exercise | A | 0.42 | 150,000 | 62,355 | 150,000 | |
Jan 03 2019 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Interim CEO | Option Exercise | A | 0.42 | 200,000 | 83,140 | 200,000 | |
Dec 12 2018 | SNSS | SUNESIS PHARMACEUT ... | Quinn William P. | CFO,Sr.V.P. Finance ... | Buy | P | 0.47 | 40,000 | 18,800 | 52,000 | 12 K to 52 K (+333.33 %) |
Jul 03 2018 | SNSS | SUNESIS PHARMACEUT ... | Pearce Homer L | Director | Option Exercise | A | 2.12 | 25,000 | 53,000 | 25,000 | |
Jul 03 2018 | SNSS | SUNESIS PHARMACEUT ... | STUMP DAVID C | Director | Option Exercise | A | 2.12 | 25,000 | 53,000 | 25,000 | |
Jul 03 2018 | SNSS | SUNESIS PHARMACEUT ... | Ketchum Steven B | Director | Option Exercise | A | 2.12 | 25,000 | 53,000 | 25,000 | |
Jul 03 2018 | SNSS | SUNESIS PHARMACEUT ... | Carchedi Steve | Director | Option Exercise | A | 2.12 | 25,000 | 53,000 | 25,000 | |
Jul 03 2018 | SNSS | SUNESIS PHARMACEUT ... | YOUNG JAMES W | Director | Option Exercise | A | 2.12 | 25,000 | 53,000 | 25,000 | |
Jul 03 2018 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Interim CEO | Option Exercise | A | 2.12 | 25,000 | 53,000 | 25,000 | |
Jul 03 2018 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Interim CEO | Option Exercise | A | 2.12 | 200,000 | 424,000 | 200,000 | |
Jul 03 2018 | SNSS | SUNESIS PHARMACEUT ... | Wolff Henry Ward | Director | Option Exercise | A | 2.12 | 6,250 | 13,250 | 6,250 | |
Jul 03 2018 | SNSS | SUNESIS PHARMACEUT ... | Wolff Henry Ward | Director | Option Exercise | A | 6.80 | 37,500 | 255,000 | 37,500 | |
Jan 02 2018 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Interim CEO | Option Exercise | A | 3.69 | 200,000 | 738,000 | 200,000 | |
Dec 04 2017 | SNSS | SUNESIS PHARMACEUT ... | Quinn William P. | CFO,Sr.V.P. Finance ... | Option Exercise | A | 2.89 | 232,500 | 671,925 | 232,500 | |
Nov 06 2017 | SNSS | SUNESIS PHARMACEUT ... | MPM Oncology Impact Management ... | 10% Owner | Buy | P | 2.77 | 16,200 | 44,874 | 3,331,500 | 3.3 M to 3.3 M (+0.49 %) |
Nov 06 2017 | SNSS | SUNESIS PHARMACEUT ... | MPM Oncology Impact Management ... | 10% Owner | Buy | P | 2.89 | 40,000 | 115,600 | 3,315,300 | 3.3 M to 3.3 M (+1.22 %) |
Nov 06 2017 | SNSS | SUNESIS PHARMACEUT ... | MPM Oncology Impact Management ... | 10% Owner | Buy | P | 2.59 | 25,300 | 65,527 | 3,275,300 | 3.3 M to 3.3 M (+0.78 %) |
Oct 30 2017 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Option Exercise | P | 3.00 | 3,740 | 11,220 | 3,740 | |
Oct 30 2017 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Option Exercise | P | 3.00 | 196,260 | 588,780 | 196,260 | |
Oct 30 2017 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Buy | P | 2.00 | 7,480 | 14,960 | 30,456 | 23 K to 30.5 K (+32.56 %) |
Oct 30 2017 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Buy | P | 2.00 | 392,520 | 785,040 | 1,598,260 | 1.2 M to 1.6 M (+32.55 %) |
Jul 12 2017 | SNSS | SUNESIS PHARMACEUT ... | Swisher Daniel N JR | President and CEO | Option Exercise | A | 2.62 | 240,177 | 629,264 | 240,177 | |
Jul 12 2017 | SNSS | SUNESIS PHARMACEUT ... | Swisher Daniel N JR | President and CEO | Option Exercise | A | 2.62 | 17,582 | 46,065 | 17,582 | |
Jul 12 2017 | SNSS | SUNESIS PHARMACEUT ... | Swisher Daniel N JR | President and CEO | Option Exercise | D | 10.20 | 50,000 | 510,000 | 0 | |
Jul 12 2017 | SNSS | SUNESIS PHARMACEUT ... | Swisher Daniel N JR | President and CEO | Option Exercise | D | 39.30 | 50,001 | 1,965,039 | 0 | |
Jul 12 2017 | SNSS | SUNESIS PHARMACEUT ... | Swisher Daniel N JR | President and CEO | Option Exercise | D | 31.32 | 50,000 | 1,566,000 | 0 | |
Jul 12 2017 | SNSS | SUNESIS PHARMACEUT ... | Swisher Daniel N JR | President and CEO | Option Exercise | D | 10.44 | 70,834 | 739,507 | 0 | |
Jul 12 2017 | SNSS | SUNESIS PHARMACEUT ... | Swisher Daniel N JR | President and CEO | Option Exercise | D | 12.54 | 118,435 | 1,485,175 | 0 | |
Jul 12 2017 | SNSS | SUNESIS PHARMACEUT ... | Swisher Daniel N JR | President and CEO | Option Exercise | D | 17.64 | 18,333 | 323,394 | 0 | |
Jul 12 2017 | SNSS | SUNESIS PHARMACEUT ... | Swisher Daniel N JR | President and CEO | Option Exercise | D | 93.24 | 4,306 | 401,491 | 0 | |
Jun 02 2017 | SNSS | SUNESIS PHARMACEUT ... | STUMP DAVID C | Director | Option Exercise | A | 2.96 | 25,000 | 74,000 | 25,000 | |
Jun 02 2017 | SNSS | SUNESIS PHARMACEUT ... | Pearce Homer L | Director | Option Exercise | A | 2.96 | 25,000 | 74,000 | 25,000 | |
Jun 02 2017 | SNSS | SUNESIS PHARMACEUT ... | Ketchum Steven B | Director | Option Exercise | A | 2.96 | 25,000 | 74,000 | 25,000 | |
Jun 02 2017 | SNSS | SUNESIS PHARMACEUT ... | Parker Geoffrey M. | Director | Option Exercise | A | 2.96 | 25,000 | 74,000 | 25,000 | |
Jun 02 2017 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Option Exercise | A | 2.96 | 25,000 | 74,000 | 25,000 | |
Jun 02 2017 | SNSS | SUNESIS PHARMACEUT ... | Carchedi Steve | Director | Option Exercise | A | 2.96 | 25,000 | 74,000 | 25,000 | |
Jun 02 2017 | SNSS | SUNESIS PHARMACEUT ... | YOUNG JAMES W | Director | Option Exercise | A | 2.96 | 25,000 | 74,000 | 25,000 | |
Dec 12 2016 | SNSS | SUNESIS PHARMACEUT ... | Parker Geoffrey M. | Director | Buy | P | 3.90 | 594 | 2,318 | 65,745 | 65.2 K to 65.7 K (+0.91 %) |
Dec 12 2016 | SNSS | SUNESIS PHARMACEUT ... | Parker Geoffrey M. | Director | Buy | P | 3.87 | 3,146 | 12,159 | 65,151 | 62 K to 65.2 K (+5.07 %) |
Dec 02 2016 | SNSS | SUNESIS PHARMACEUT ... | BJERKHOLT ERIC | EVP, CFO & Corp. Se ... | Option Exercise | A | 4.03 | 95,000 | 382,850 | 95,000 | |
Dec 02 2016 | SNSS | SUNESIS PHARMACEUT ... | Swisher Daniel N JR | President and CEO | Option Exercise | A | 4.03 | 240,000 | 967,200 | 240,000 | |
Jul 05 2016 | SNSS | SUNESIS PHARMACEUT ... | Pearce Homer L | Director | Option Exercise | A | 0.55 | 50,000 | 27,385 | 50,000 | |
Jul 05 2016 | SNSS | SUNESIS PHARMACEUT ... | Fust Matthew | Director | Option Exercise | A | 0.55 | 50,000 | 27,385 | 50,000 | |
Jul 05 2016 | SNSS | SUNESIS PHARMACEUT ... | Ketchum Steven B | Director | Option Exercise | A | 0.55 | 50,000 | 27,385 | 50,000 | |
Jul 05 2016 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Option Exercise | A | 0.55 | 50,000 | 27,385 | 50,000 | |
Jul 05 2016 | SNSS | SUNESIS PHARMACEUT ... | Carchedi Steve | Director | Option Exercise | A | 0.55 | 50,000 | 27,385 | 50,000 | |
Jul 05 2016 | SNSS | SUNESIS PHARMACEUT ... | STUMP DAVID C | Director | Option Exercise | A | 0.55 | 50,000 | 27,385 | 50,000 | |
Jul 05 2016 | SNSS | SUNESIS PHARMACEUT ... | YOUNG JAMES W | Director | Option Exercise | A | 0.55 | 50,000 | 27,385 | 50,000 | |
May 27 2016 | SNSS | SUNESIS PHARMACEUT ... | Parker Geoffrey M. | Director | Buy | P | 0.47 | 9,500 | 4,455 | 62,005 | 52.5 K to 62 K (+18.09 %) |
May 26 2016 | SNSS | SUNESIS PHARMACEUT ... | Parker Geoffrey M. | Director | Buy | P | 0.49 | 22,505 | 10,933 | 52,505 | 30 K to 52.5 K (+75.02 %) |
May 26 2016 | SNSS | SUNESIS PHARMACEUT ... | Parker Geoffrey M. | Director | Buy | P | 0.46 | 30,000 | 13,881 | 30,000 | 0 to 30 K |
Apr 01 2016 | SNSS | SUNESIS PHARMACEUT ... | Parker Geoffrey M. | Director | Option Exercise | A | 0.54 | 75,000 | 40,500 | 75,000 | |
Mar 02 2016 | SNSS | SUNESIS PHARMACEUT ... | BJERKHOLT ERIC | EVP, CFO & Corp. Se ... | Payment of Exercise | F | 0.75 | 34,991 | 26,243 | 100,922 | 135.9 K to 100.9 K (-25.75 %) |
Mar 02 2016 | SNSS | SUNESIS PHARMACEUT ... | BJERKHOLT ERIC | EVP, CFO & Corp. Se ... | Grant | A | 0.00 | 80,000 | 0 | 135,913 | 55.9 K to 135.9 K (+143.08 %) |
Mar 02 2016 | SNSS | SUNESIS PHARMACEUT ... | Swisher Daniel N JR | President and CEO | Payment of Exercise | F | 0.75 | 55,675 | 41,756 | 266,519 | 322.2 K to 266.5 K (-17.28 %) |
Mar 02 2016 | SNSS | SUNESIS PHARMACEUT ... | Swisher Daniel N JR | President and CEO | Grant | A | 0.00 | 137,533 | 0 | 322,194 | 184.7 K to 322.2 K (+74.48 %) |
Dec 21 2015 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Buy | P | 0.84 | 32,725 | 27,489 | 137,859 | 105.1 K to 137.9 K (+31.13 %) |
Dec 21 2015 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Buy | P | 0.84 | 1,717,275 | 1,442,511 | 7,234,441 | 5.5 M to 7.2 M (+31.13 %) |
Dec 21 2015 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Option Exercise | X | 1.32 | 10,383 | 13,706 | 0 | |
Dec 21 2015 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Option Exercise | X | 1.32 | 20,766 | 27,411 | 0 | |
Dec 21 2015 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Option Exercise | X | 1.32 | 544,893 | 719,259 | 0 | |
Dec 21 2015 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Option Exercise | X | 1.32 | 1,089,788 | 1,438,520 | 0 | |
Dec 21 2015 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Sell | S | 3.64 | 3,962 | 14,422 | 105,134 | 109.1 K to 105.1 K (-3.63 %) |
Dec 21 2015 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Buy | X | 1.32 | 10,383 | 13,706 | 109,096 | 98.7 K to 109.1 K (+10.52 %) |
Dec 21 2015 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Sell | S | 3.46 | 7,925 | 27,421 | 98,713 | 106.6 K to 98.7 K (-7.43 %) |
Dec 21 2015 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Buy | X | 1.32 | 20,766 | 27,411 | 106,638 | 85.9 K to 106.6 K (+24.18 %) |
Dec 21 2015 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Sell | S | 3.46 | 207,938 | 719,465 | 5,517,166 | 5.7 M to 5.5 M (-3.63 %) |
Dec 21 2015 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Buy | X | 1.32 | 544,893 | 719,259 | 5,725,104 | 5.2 M to 5.7 M (+10.52 %) |
Dec 21 2015 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Sell | S | 3.46 | 415,877 | 1,438,934 | 5,180,211 | 5.6 M to 5.2 M (-7.43 %) |
Dec 21 2015 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Buy | X | 1.32 | 1,089,788 | 1,438,520 | 5,596,088 | 4.5 M to 5.6 M (+24.18 %) |
Dec 02 2015 | SNSS | SUNESIS PHARMACEUT ... | BJERKHOLT ERIC | EVP, CFO & Corp. Se ... | Option Exercise | A | 1.03 | 270,000 | 278,100 | 270,000 | |
Dec 02 2015 | SNSS | SUNESIS PHARMACEUT ... | Swisher Daniel N JR | President and CEO | Option Exercise | A | 1.03 | 660,000 | 679,800 | 660,000 | |
Aug 26 2015 | SNSS | SUNESIS PHARMACEUT ... | Swisher Daniel N JR | President and CEO | Buy | P | 1.01 | 12,216 | 12,338 | 199,736 | 187.5 K to 199.7 K (+6.51 %) |
Aug 26 2015 | SNSS | SUNESIS PHARMACEUT ... | Swisher Daniel N JR | President and CEO | Buy | P | 1.01 | 12,784 | 12,912 | 187,520 | 174.7 K to 187.5 K (+7.32 %) |
Jul 28 2015 | SNSS | SUNESIS PHARMACEUT ... | Ketchum Steven B | Director | Option Exercise | X | 1.32 | 5,551 | 7,327 | 0 | |
Jul 28 2015 | SNSS | SUNESIS PHARMACEUT ... | Ketchum Steven B | Director | Option Exercise | X | 1.32 | 11,105 | 14,659 | 0 | |
Jul 28 2015 | SNSS | SUNESIS PHARMACEUT ... | Ketchum Steven B | Director | Sell | S | 3.46 | 2,119 | 7,329 | 84,259 | 86.4 K to 84.3 K (-2.45 %) |
Jul 28 2015 | SNSS | SUNESIS PHARMACEUT ... | Ketchum Steven B | Director | Buy | X | 1.32 | 5,551 | 7,327 | 86,378 | 80.8 K to 86.4 K (+6.87 %) |
Jul 28 2015 | SNSS | SUNESIS PHARMACEUT ... | Ketchum Steven B | Director | Sell | S | 3.46 | 4,239 | 14,661 | 80,827 | 85.1 K to 80.8 K (-4.98 %) |
Jul 28 2015 | SNSS | SUNESIS PHARMACEUT ... | Ketchum Steven B | Director | Buy | X | 1.32 | 11,105 | 14,659 | 85,066 | 74 K to 85.1 K (+15.01 %) |
Jul 28 2015 | SNSS | SUNESIS PHARMACEUT ... | BJERKHOLT ERIC | EVP, CFO & Corp. Se ... | Option Exercise | X | 1.32 | 5,551 | 7,327 | 0 | |
Jul 28 2015 | SNSS | SUNESIS PHARMACEUT ... | BJERKHOLT ERIC | EVP, CFO & Corp. Se ... | Option Exercise | X | 1.32 | 11,105 | 14,659 | 0 | |
Jul 28 2015 | SNSS | SUNESIS PHARMACEUT ... | BJERKHOLT ERIC | EVP, CFO & Corp. Se ... | Sell | S | 3.46 | 2,119 | 7,329 | 83,827 | 85.9 K to 83.8 K (-2.47 %) |
Jul 28 2015 | SNSS | SUNESIS PHARMACEUT ... | BJERKHOLT ERIC | EVP, CFO & Corp. Se ... | Buy | X | 1.32 | 5,551 | 7,327 | 85,946 | 80.4 K to 85.9 K (+6.90 %) |
Jul 28 2015 | SNSS | SUNESIS PHARMACEUT ... | BJERKHOLT ERIC | EVP, CFO & Corp. Se ... | Sell | S | 3.46 | 4,239 | 14,661 | 80,395 | 84.6 K to 80.4 K (-5.01 %) |
Jul 28 2015 | SNSS | SUNESIS PHARMACEUT ... | BJERKHOLT ERIC | EVP, CFO & Corp. Se ... | Buy | X | 1.32 | 11,105 | 14,659 | 84,634 | 73.5 K to 84.6 K (+15.10 %) |
Jul 28 2015 | SNSS | SUNESIS PHARMACEUT ... | Swisher Daniel N JR | President and CEO | Option Exercise | X | 1.32 | 11,105 | 14,659 | 0 | |
Jul 28 2015 | SNSS | SUNESIS PHARMACEUT ... | Swisher Daniel N JR | President and CEO | Option Exercise | X | 1.32 | 22,210 | 29,317 | 0 | |
Jul 28 2015 | SNSS | SUNESIS PHARMACEUT ... | Swisher Daniel N JR | President and CEO | Buy | P | 1.02 | 25,000 | 25,458 | 174,336 | 149.3 K to 174.3 K (+16.74 %) |
Jul 28 2015 | SNSS | SUNESIS PHARMACEUT ... | Swisher Daniel N JR | President and CEO | Sell | S | 3.46 | 4,238 | 14,657 | 149,736 | 154 K to 149.7 K (-2.75 %) |
Jul 28 2015 | SNSS | SUNESIS PHARMACEUT ... | Swisher Daniel N JR | President and CEO | Buy | X | 1.32 | 11,105 | 14,659 | 153,974 | 142.9 K to 154 K (+7.77 %) |
Jul 28 2015 | SNSS | SUNESIS PHARMACEUT ... | Swisher Daniel N JR | President and CEO | Sell | S | 3.46 | 8,477 | 29,318 | 142,869 | 151.3 K to 142.9 K (-5.60 %) |
Jul 28 2015 | SNSS | SUNESIS PHARMACEUT ... | Swisher Daniel N JR | President and CEO | Buy | X | 1.32 | 22,210 | 29,317 | 151,346 | 129.1 K to 151.3 K (+17.20 %) |
Jul 28 2015 | SNSS | SUNESIS PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Option Exercise | X | 1.32 | 10,383 | 13,706 | 0 | |
Jul 28 2015 | SNSS | SUNESIS PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Option Exercise | X | 1.32 | 20,766 | 27,411 | 0 | |
Jul 28 2015 | SNSS | SUNESIS PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Option Exercise | X | 1.32 | 544,893 | 719,259 | 0 | |
Jul 28 2015 | SNSS | SUNESIS PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Option Exercise | X | 1.32 | 1,089,788 | 1,438,520 | 0 | |
Jul 28 2015 | SNSS | SUNESIS PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Sell | S | 3.46 | 3,962 | 13,709 | 5,623,815 | 5.6 M to 5.6 M (-0.07 %) |
Jul 28 2015 | SNSS | SUNESIS PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | X | 1.32 | 10,383 | 13,706 | 5,627,777 | 5.6 M to 5.6 M (+0.18 %) |
Jul 28 2015 | SNSS | SUNESIS PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Sell | S | 3.46 | 7,925 | 27,421 | 5,617,394 | 5.6 M to 5.6 M (-0.14 %) |
Jul 28 2015 | SNSS | SUNESIS PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | X | 1.32 | 20,766 | 27,411 | 5,625,319 | 5.6 M to 5.6 M (+0.37 %) |
Jul 28 2015 | SNSS | SUNESIS PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Sell | S | 3.46 | 207,938 | 719,465 | 5,604,553 | 5.8 M to 5.6 M (-3.58 %) |
Jul 28 2015 | SNSS | SUNESIS PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | X | 1.32 | 544,893 | 719,259 | 5,812,491 | 5.3 M to 5.8 M (+10.34 %) |
Jul 28 2015 | SNSS | SUNESIS PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Sell | S | 3.46 | 415,877 | 1,438,934 | 5,267,598 | 5.7 M to 5.3 M (-7.32 %) |
Jul 28 2015 | SNSS | SUNESIS PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | X | 1.32 | 1,089,788 | 1,438,520 | 5,683,475 | 4.6 M to 5.7 M (+23.72 %) |
Jul 01 2015 | SNSS | SUNESIS PHARMACEUT ... | Carchedi Steve | Director | Option Exercise | A | 3.01 | 40,000 | 120,400 | 40,000 | |
Jul 01 2015 | SNSS | SUNESIS PHARMACEUT ... | Fust Matthew | Director | Option Exercise | A | 3.01 | 40,000 | 120,400 | 40,000 | |
Jul 01 2015 | SNSS | SUNESIS PHARMACEUT ... | Ketchum Steven B | Director | Option Exercise | A | 3.01 | 40,000 | 120,400 | 40,000 |